Insider Trading - Monte Rosa Therapeutics Inc. (GLUE)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-28 Purchase | 2021-06-30 4:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner | 600,000 | $19 | $11,400,000 | 3,202,200 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 5:00 pm | Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 157,895 | $19 | $3,000,005 | 8,897,053 (Indirect Direct) | View |
| 2021-06-28 Purchase | 2021-06-30 5:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 5:59 pm | Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Direct) | View |
| 2021-06-28 Purchase | 2021-06-30 6:00 pm | Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:01 pm | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:02 pm | Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:02 pm | Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:06 pm | Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:06 pm | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:07 pm | Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
| 2021-06-28 Purchase | 2021-06-30 6:09 pm | Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-23 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director | 47,132 | $0 | 47,132 (Direct) | View |
| 2021-02-24 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 47,132 | $0 | 9,896,460 (Direct) | View |
| 2021-02-24 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 3,575,000 | $2 | 9,896,460 (Indirect) | View |
| 2021-02-24 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 2,699,328 | $2.9637 | 9,896,460 (Indirect) | View |
| 2021-06-23 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 387,069 | $0 | 387,069 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:00 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 500,367 | $0 | 500,367 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:00 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus Director | 680,140 | $0 | 680,140 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:00 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 54,213 | $0 | 54,213 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:01 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director | 54,213 | $0 | 54,213 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 5:01 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 47,132 | $0 | 47,132 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 5:01 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Leo Chandra P. Director | 47,132 | $0 | 47,132 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:01 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim CFO | 157,587 | $0 | 157,587 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 5:47 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 47,132 | $0 | 47,132 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 4:08 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner | 5,204,400 | $0 | 3,202,200 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 38,309,520 | $0 | 8,897,053 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 5:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 38,309,520 | $0 | 2,097,938 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 5:59 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 30,092,935 | $0 | 7,692,298 (Direct) | View |
| 2021-06-28 Conversion | 2021-06-30 6:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:01 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:02 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:02 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:04 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:06 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:06 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:07 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:08 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:08 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
| 2021-06-28 Conversion | 2021-06-30 6:09 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |